Our Blog
Newsweek: A Common Drug Offers New Hope to People With Severe Hair Loss
Keith comments on research showing upadacitinib, a JAK-inhibitor drug, can regrow hair in people with severe alopecia areata, and what it means for patients.
Dr. Keith Kantor, trichologist and clinical director at ReGen Therapeutics, was featured in Newsweek.
Keith comments on research showing upadacitinib, a JAK-inhibitor drug, can regrow hair in people with severe alopecia areata, and what it means for patients.
Read the full article at Newsweek
If you're seeing signs of thinning, schedule a consultation with our team.